COVID-19 in hemodialysis patients: New insights into metabolomic profile dynamics from 60 days pre- to 60 days post-diagnosis
PLOS One · 17.04.2026 · 21 (4) · e0346687
DOI: 10.1371/journal.pone.0346687 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift PLOS One, online erschienen am 17.04.2026. Verfasst von Gabriela F Dias und 11 weiteren Autor:innen. Beteiligte Einrichtung: Renal Research Institute, New York, New York, United States of America. Hauptthemen laut MEDLINE: Renal Dialysis, COVID-19, Metabolome. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Background
Maintenance hemodialysis patients experience higher morbidity and mortality from COVID-19, partly due to comorbidities like diabetes and cardiovascular disease. However, kidney disease-related metabolic processes may also contribute.
Methods
In this prospective, multi-center, observational study, we analyzed 201 routine serum samples from 30 hemodialysis patients (average age 59.2 ± 13.3 years, 57% male) with confirmed COVID-19, collected from 60 days before and 60 days after diagnosis. Untargeted liquid chromatography/mass spectrometry was used to profile metabolites. Linear and semi-parametric mixed-effects models were applied to assess changes across four phases: baseline (−60 to −15 days), putative incubation period (PIP; −14–0 days), acute (1–14 days), and post-COVID (15–60 days). Because infection and symptoms may vary across individuals, −14–0 days were used as an approximate pre-diagnosis window rather than a precise incubation interval.
Results
Among 417 metabolomic features, 10 showed significant changes between baseline and PIP. Two metabolites, α-guanidinoglutaric acid and N-acetylneuraminic acid, were identified through library matching, while the remainder were characterized by mass and retention time. Temporal analysis revealed both transient metabolic shifts, which returned to baseline, and persistent changes, which remained altered post-COVID.
Conclusions
These findings suggest that early metabolic changes before COVID-19 diagnosis may be detected in routine serum samples, offering opportunities to develop predictive models for early detection. Identifying these unique metabolomics fingerprints could improve personalized surveillance strategies and enhance understanding of COVID-19’s impact on hemodialysis patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Renal Research Institute, New York, New York, United States of America.
- Department of Statistics and Applied Probability, University of California, Santa Barbara, California, United States of America.
- Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
- Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
ORCID-Profile: Chenxi Fan, Nadja Grobe
Förderung
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Dias, G. F., Fan, C., Han, M., Wang, X., Thwin, O., Fuentes, L., Wang, X., Zhang, H., Guo, W., Kotanko, P., Grobe, N., & Wang, Y. (2026). COVID-19 in hemodialysis patients: New insights into metabolomic profile dynamics from 60 days pre- to 60 days post-diagnosis. PLOS One, 21(4), e0346687. https://doi.org/10.1371/journal.pone.0346687
Vancouver
Dias GF, Fan C, Han M, Wang X, Thwin O, Fuentes L, et al. COVID-19 in hemodialysis patients: New insights into metabolomic profile dynamics from 60 days pre- to 60 days post-diagnosis. PLOS One. 2026;21(4):e0346687. doi:10.1371/journal.pone.0346687
BibTeX
@article{Dias2026,
author = {Dias, Gabriela F and Fan, Chenxi and Han, Maggie and Wang, Xiaoling and Thwin, Ohnmar and Fuentes, Lemuel and Wang, Xin and Zhang, Hanjie and Guo, Wensheng and Kotanko, Peter and Grobe, Nadja and Wang, Yuedong},
title = {COVID-19 in hemodialysis patients: New insights into metabolomic profile dynamics from 60 days pre- to 60 days post-diagnosis},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {4},
pages = {e0346687},
doi = {10.1371/journal.pone.0346687}
}
EUVIMED